PGP and breast cancer: The siRNA used for knocking down P-gp expression was actually selected by Meng et al.40 from a panel of siRNAs by high throughput screening of their efficiency of silencing P-gp in a multi-drug resistant breast cancer cell line that maintained stable P-gp expression.